Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

To Enhance Cognition in Late Life Depression Using Transcranial Direct Current Stimulation

22 de enero de 2018 actualizado por: Tarek Rajji, Centre for Addiction and Mental Health

Enhancing Cognition in Patients With Late-Life Depression: A Randomized Controlled Trial of Transcranial Direct Current Stimulation

Late Life Depression (LLD) is a serious health problem which not only causes depressed mood but also results in impairments in memory and attention. These impairments are likely to be resistant to treatment, which increases the chances of developing dementia even after successful treatment of mood.This study is a randomized controlled trial of transcranial Direct Current Stimulation (tDCS) in people with LLD to enhance their cognition after successful treatment of mood with established medications. tDCS is non invasive, relatively inexpensive and portable, and has been found to be safe.This study also serves as a pilot study to assess the effects of tDCS on cognition and neurophysiologic markers of cognition among patients with LLD. Primary study hypothesis is that participants Participants randomized to tDCS will perform better on a working memory task 2 weeks and 3 months following the tDCS course.

Descripción general del estudio

Estado

Terminado

Condiciones

Descripción detallada

tDCS is a non-invasive brain stimulation method that utilizes low intensity electrical current either to increase cortical excitability with an anodal electrode or to suppress cortical excitability with a cathodal electrode. tDCS produces its effects through long lasting changes in neuroplasticity: in animal studies, tDCS results in long-term potentiation and brain-derived neurotrophic factor secretion; in human studies, tDCS results in potentiation of neurophysiologic markers of neuroplasticity. Consistent with these preclinical findings, tDCS to the temporoparietal cortex or left DLPFC improves memory in patients with mild to moderate Alzheimer disease(AD). tDCS has also been tested among patients with depression - including by our group - but mainly as a treatment for depressive symptoms. In one recent large study one session of bilateral anodal tDCS was shown to enhance working memory among midlife participants with major depression prior to receiving any treatment. However, it is still not known (1) whether tDCS improves cognition beyond the partial improvement that is associated with resolution of depressive symptoms; or (2) whether it has a more fundamental and long lasting effect on cognition.

This trial will assess the acute and long-term effects of a 2-week course of daily (5 days/week) bilateral anodal tDCS of the DLPFC on cognition, and in particular working memory among 36 patients with LLD. We will recruit and randomize participants who have already been treated for LLD prior to consenting to the study and who still meet criteria for remission while on antidepressant medications.

This trial will also be used as a platform to explore the effect of tDCS on neurophysiologic measures of plasticity during working memory performance. Working memory is supported by re-entrant circuits, some are local within the DLPFC and others are long-range connecting the DLPFC to more posterior cortices. These networks result in high and low frequency neuronal oscillations that can be captured by electroencephalography (EEG). Using novel neurophysiologic analyses, our group and others have demonstrated that the modulation of high-frequency (particularly gamma) oscillations by low-frequency (particularly theta) oscillations - "theta-gamma coupling" - is a neurophysiologic marker of working memory. Thus, we will explore the effect of tDCS on theta-gamma coupling.

Tipo de estudio

Intervencionista

Inscripción (Actual)

36

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Ontario
      • Toronto, Ontario, Canadá, M6J1H4
        • Center for Addiction and Mental Health

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

60 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  1. Women and men of any races or ethnicity
  2. Age 60 and above
  3. Major depressive disorder, single or recurrent per SCID DSM-IV criteria AND remission from that episode as defined by DSM IV-TR criteria for remission.
  4. Montgomery-Asberg Depression Rating Scale (MADRS) score less than 10.
  5. Ability to speak English fluently enough to complete all research assessments.
  6. Corrected visual ability to read newspaper headlines; hearing capacity to respond to a raised conversational voice
  7. Willingness and ability to provide consent

Exclusion Criteria:

  1. DSM IV TR criteria for any dementia
  2. DSM IV TR criteria for life-time bipolar disorder, schizophrenia, schizoaffective disorder, or other psychotic disorders
  3. DSM IV TR criteria for any substance abuse or dependence within the past 6 months
  4. Presence of psychotic features or any other symptoms that would make the participant unable to participate in the study.
  5. Any medical contra-indications to tDCS.
  6. Electroconvulsive therapy in the last 6 months.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Active TDCS
2-week course of daily (5 days/week) active bilateral anodal TDCS, duration 30 minute each session. Current 2 mA.
Active Stimulation
Comparador falso: Sham TDCS
2-week course of daily (5 days/week) Sham bilateral tDCS. Duration 30 minute each session.
Sham Stimulation

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
To compare performance on working memory task (N-Back) and neuropsychological battery between active and sham TDCS groups
Periodo de tiempo: Two weeks following the TDCS course
Two weeks following the TDCS course

Medidas de resultado secundarias

Medida de resultado
Periodo de tiempo
To compare performance on working memory task (N-Back) and neuropsychological battery between active and sham TDCS groups
Periodo de tiempo: Three months following the TDCS course
Three months following the TDCS course

Otras medidas de resultado

Medida de resultado
Periodo de tiempo
To compare theta-gamma coupling as measured by electroencephalography between active and sham TDCS groups.
Periodo de tiempo: Two weeks following the TDCS
Two weeks following the TDCS
To compare theta-gamma coupling as measured by electroencephalography between active and sham TDCS groups.
Periodo de tiempo: 3 months following the TDCS
3 months following the TDCS

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Tarek K Rajji, MD, Center for Addiction and Mental Health

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de mayo de 2014

Finalización primaria (Actual)

1 de noviembre de 2017

Finalización del estudio (Actual)

1 de noviembre de 2017

Fechas de registro del estudio

Enviado por primera vez

6 de agosto de 2014

Primero enviado que cumplió con los criterios de control de calidad

7 de agosto de 2014

Publicado por primera vez (Estimar)

8 de agosto de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

24 de enero de 2018

Última actualización enviada que cumplió con los criterios de control de calidad

22 de enero de 2018

Última verificación

1 de enero de 2018

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 131/2013

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Active TDCS

Suscribir